Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
US8445507B2 · kind B2 · utility
54Cited by
52References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2007 |
| Grant date | May 21, 2013 |
| Priority date | — |
| Expiry date | Nov 16, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A hydantoin compound useful for the prevention or treatment of hyperproliferative diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.